<SEC-DOCUMENT>0001193125-25-042772.txt : 20250228
<SEC-HEADER>0001193125-25-042772.hdr.sgml : 20250228
<ACCEPTANCE-DATETIME>20250228170331
ACCESSION NUMBER:		0001193125-25-042772
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20250228
DATE AS OF CHANGE:		20250228
EFFECTIVENESS DATE:		20250228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aldeyra Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001341235
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-285460
		FILM NUMBER:		25691910

	BUSINESS ADDRESS:	
		STREET 1:		131 HARTWELL AVENUE
		STREET 2:		SUITE 320
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421
		BUSINESS PHONE:		781-761-4904

	MAIL ADDRESS:	
		STREET 1:		131 HARTWELL AVENUE
		STREET 2:		SUITE 320
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aldexa Therapeutics, Inc.
		DATE OF NAME CHANGE:	20130102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Neuron Systems Inc
		DATE OF NAME CHANGE:	20051012
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d892172ds8.htm
<DESCRIPTION>S-8
<TEXT>
<HTML><HEAD>
<TITLE>S-8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on February&nbsp;28, 2025 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-&#8195;&#8195;&#8195;&#8195;</FONT> </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">S-8</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>ALDEYRA THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">20-1968197</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>131 Hartwell Avenue, Suite 320</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Lexington, MA</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>02421</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of Principal Executive Offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2016 Employee Stock Purchase Plan </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Full title of plan) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Todd C. Brady, M.D., Ph.D., </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>President and Chief Executive Officer </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>131 Hartwell Avenue, Suite 320 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Lexington, MA 02421 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name
and address of agent for service) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(781) <FONT STYLE="white-space:nowrap">761-4904</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Telephone number, including area code, of agent for service) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Please send copies of all communications to: </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Keith J. Scherer </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Gunderson Dettmer Stough Villeneuve Franklin&nbsp;&amp; Hachigian, LLP </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>One Marina Park Drive, Suite 900 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Boston, MA 02210 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Telephone: (617) <FONT STYLE="white-space:nowrap">648-9100</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Telecopy: (617) <FONT STYLE="white-space:nowrap">648-9199</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <FONT STYLE="white-space:nowrap">non-accelerated</FONT>
filer, a smaller reporting company or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company,&#148; and &#147;emerging growth company&#148; in Rule <FONT
STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-accelerated</FONT> filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&#8194;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXPLANATORY NOTE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> registers additional shares of Common Stock to be issued pursuant to the
Purchase Plan. The information contained in the Registrant&#146;s registration statements on Form <FONT STYLE="white-space:nowrap">S-8</FONT> (SEC File Nos. <A HREF="http://www.sec.gov/Archives/edgar/data/1341235/000119312519069189/d716947ds8.htm"><U>
<FONT STYLE="white-space:nowrap">333-230161</FONT></U></A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1341235/000119312518102096/d545154ds8.htm"><U><FONT STYLE="white-space:nowrap">333-224019</FONT></U></A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1341235/000119312517104243/d368263ds8.htm">
<U><FONT STYLE="white-space:nowrap">333-217043</FONT></U></A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1341235/000119312516677537/d153477ds8.htm"><U><FONT STYLE="white-space:nowrap">333-213045</FONT></U></A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1341235/000119312520071672/d847470ds8.htm">
<U><FONT STYLE="white-space:nowrap">333-237129</FONT></U></A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1341235/000119312521077845/d152129ds8.htm"><U><FONT STYLE="white-space:nowrap">333-254144</FONT></U></A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1341235/000119312522078435/d335510ds8.htm">
<U><FONT STYLE="white-space:nowrap">333-263660</FONT></U></A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1341235/000119312523066127/d675707ds8.htm"><FONT STYLE="white-space:nowrap">333-270401</FONT></A> and <A HREF="http://www.sec.gov/Archives/edgar/data/1341235/000119312524062277/d748506ds8.htm">
<FONT STYLE="white-space:nowrap">333-277752</FONT></A>), together with all exhibits filed therewith or incorporated therein by reference, are hereby incorporated by reference pursuant to General Instruction E to Form
<FONT STYLE="white-space:nowrap">S-8.</FONT> </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;8. <U>Exhibits. </U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Description of Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>5.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d892172dex51.htm">Opinion of Gunderson Dettmer Stough Villeneuve Franklin&nbsp;&amp; Hachigian, LLP. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d892172dex231.htm">Consent of BDO USA, P.C., independent registered public accounting firm. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d892172dex51.htm">Consent of Gunderson Dettmer Stough Villeneuve Franklin&nbsp;&amp; Hachigian, LLP (included in Exhibit 5.1). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#sig">Power of Attorney (included in the signature page to the registration statement). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>107*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d892172dexfilingfees.htm">Filing Fee Table. </A></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">*&#8201;&#8201;Filed herewith.</P></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form <FONT STYLE="white-space:nowrap">S-8</FONT> and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Lexington, Commonwealth of Massachusetts, on this
28th day of February, 2025. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>ALDEYRA THERAPEUTICS, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Todd C. Brady, M.D., Ph.D.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Todd C. Brady, M.D., Ph.D.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>President and Chief Executive Officer</B></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sig"></A>POWER OF ATTORNEY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>KNOW ALL PERSONS BY THESE PRESENTS</B>, that the undersigned officers and directors of Aldeyra Therapeutics, Inc., a Delaware corporation, do hereby
constitute and appoint Todd C. Brady, M.D., Ph.D. and Michael Alfieri, and each of them, the lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents with full power and authority to do any
and all acts and things and to execute any and all instruments which said attorneys and agents, and any one of them, determine may be necessary or advisable or required to enable said corporation to comply with the Securities Act, and any rules or
regulations or requirements of the Securities and Exchange Commission in connection with this Registration Statement. Without limiting the generality of the foregoing power and authority, the powers granted include the power and authority to sign
the names of the undersigned officers and directors in the capacities indicated below to this Registration Statement, to any and all amendments, both <FONT STYLE="white-space:nowrap">pre-effective</FONT> and post-effective, and supplements to this
Registration Statement, and to any and all instruments or documents filed as part of or in conjunction with this Registration Statement or amendments or supplements thereof, and each of the undersigned hereby ratifies and confirms that all said
attorneys and agents, or any one of them, shall do or cause to be done by virtue hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act, this
Registration Statement has been signed by the following persons on behalf of the Registrant in the capacities and on the dates indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Signature</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Title</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Date</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Todd C. Brady, M.D., Ph.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Todd C. Brady, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">President,&nbsp;Chief&nbsp;Executive&nbsp;Officer&nbsp;and&nbsp;Director</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Principal Executive Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">February&nbsp;28, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Michael Alfieri</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Michael Alfieri</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Head of Finance</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Principal Financial and Accounting Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">February&nbsp;28, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Richard H. Douglas, Ph.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Richard H. Douglas, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Chairman of the Board of Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">February&nbsp;28, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Ben Bronstein, M.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Ben Bronstein, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">February&nbsp;28, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Martin J. Joyce</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Martin J. Joyce</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">February&nbsp;28, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Nancy Miller-Rich</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Nancy Miller-Rich</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">February&nbsp;28, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Gary Phillips, M.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Gary Phillips, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">February&nbsp;28, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Neal Walker, D.O.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Neal Walker, D.O.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">February&nbsp;28, 2025</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d892172dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g892172g15i76.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">February&nbsp;28, 2025 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aldeyra Therapeutics, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">131 Hartwell Avenue, Suite 320 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lexington, MA 02421 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Re: Aldeyra Therapeutics, Inc. Registration
Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> for 596,483 Shares of Common Stock </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We refer to the registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> (the &#147;Registration Statement&#148;) to be filed by Aldeyra
Therapeutics, Inc., a Delaware corporation (the &#147;Company&#148;), with the Securities and Exchange Commission (the &#147;Commission&#148;) in connection with the registration under the Securities Act of 1933, as amended (the &#147;Act&#148;) of
596,483 shares of the Company&#146;s common stock, $0.001 par value per share (the &#147;Common Stock&#148; and such shares the &#147;Shares&#148;) issuable in the aggregate under the Company&#146;s 2016 Employee Stock Purchase Plan (the
&#147;ESPP&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As your counsel, we have examined such matters of fact and questions of law as we have deemed necessary in order to render the opinion
set forth herein. In connection with our opinion expressed below, we have relied as to certain factual matters on information obtained from public officials, officers of the Company and other sources believed by us to be responsible. We express no
opinion as to matters governed by any laws other than the laws of the Delaware General Corporation Law and the federal laws of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based
upon and subject to the foregoing, we advise you that, in our opinion, when the Shares have been issued and sold pursuant to the applicable provisions of the ESPP, and in accordance with the Registration Statement, such Shares will be validly
issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares of the Company&#146;s Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing
of this opinion as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Act or the rules and regulations of the
Commission thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Gunderson Dettmer Stough Villeneuve</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Franklin&nbsp;&amp; Hachigian, LLP</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gunderson Dettmer Stough Villeneuve</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Franklin&nbsp;&amp; Hachigian, LLP</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g892172g94i30.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g892172dsp6c.jpg" ALT="LOGO" STYLE="width:8.84861in;height:0.147917in;">
 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d892172dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 23.1 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Consent of Independent Registered Public Accounting Firm </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the incorporation by reference in this Registration Statement of our report dated February&nbsp;28, 2025, relating to the consolidated
financial statements of Aldeyra Therapeutics, Inc. (the Company) appearing in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ BDO USA, P.C. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Boston, Massachusetts </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February&nbsp;28, 2025 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>d892172dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<HTML><HEAD>
<TITLE>EX-FILING FEES</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 107 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Calculation of Filing Fee Tables </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Form <FONT STYLE="white-space:nowrap">S-8</FONT> </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>(Form Type) </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Aldeyra
Therapeutics, Inc. </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>(Exact name of Registrant as Specified in its Charter) </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Table 1: Newly Registered Securities </U></P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-LEFT:1px solid #000000; padding-left:8pt">Security Type</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Security</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Class</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Title</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Fee</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Calculation</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Rule(3)</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Amount</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Registered(1)</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Proposed</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Maximum</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Offering</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Price Per</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Share</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Maximum</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Aggregate</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Offering</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Price</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Fee</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Rate</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Amount of</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Registration</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Fee(4)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-LEFT:1px solid #000000; padding-left:8pt">Equity</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Common&nbsp;stock,&#8201; par value $0.001 per share</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Rule&nbsp;457(h)</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Rule 457(c)</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">596,483&nbsp;(2)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">$5.457&nbsp;(3)</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">$3,255,007.74</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;">0.0001531</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">$498.35</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" COLSPAN="7" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="7" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-LEFT:1px solid #000000; padding-left:8pt">Total Offering Amounts</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">$3,255,007.74</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">$498.35</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" COLSPAN="7" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="7" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-LEFT:1px solid #000000; padding-left:8pt">Total Fee Offsets</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; padding-right:2pt">&#151;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" COLSPAN="7" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="7" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">Net Fee Due</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">$498.35</P></TD></TR>
</TABLE> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), this
Registration Statement shall also cover any additional shares of Registrant&#146;s common stock, par value $0.001 per share (the &#147;Common Stock&#148;), that become issuable under the Registrant&#146;s 2016 Employee Stock Purchase Plan (the
&#147;2016 ESPP&#148;), as a result of any stock dividend, stock split, recapitalization, or other similar transaction effected without the receipt of consideration that results in an increase to the number of outstanding shares of Registrant&#146;s
Common Stock, as applicable. Common Stock issuable under the 2016 ESPP were previously registered on a Registration Statement on August&nbsp;10, 2016 (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-213045),</FONT> March&nbsp;30, 2017 (File <FONT
STYLE="white-space:nowrap">No.&nbsp;333-217043),</FONT> March&nbsp;29, 2018 (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-224019),</FONT> March&nbsp;8, 2019 (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-230161),</FONT> March&nbsp;12,
2020 (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-237129),</FONT> March&nbsp;11, 2021 (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-254144),</FONT> March&nbsp;17, 2022 (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-263660),</FONT>
March&nbsp;9, 2023 (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-270401)</FONT> and March&nbsp;7, 2024 (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-277752).</FONT> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents 596,483 shares of Common Stock that were automatically added to the shares reserved for issuance
under the 2016 ESPP on January&nbsp;2, 2025 pursuant to an &#147;evergreen&#148; provision contained in the 2016 ESPP (the &#147;2016 ESPP Evergreen Shares&#148;). The number of shares of Common Stock available for issuance under the 2016 ESPP is
subject to an automatic annual increase on the first business day of each fiscal year of the Registrant equal to the least of (i) 1% of the total number of shares of Common Stock actually issued and outstanding on the last business day of the prior
fiscal year (excluding any rights to purchase shares of common shares that may be outstanding, such as options or warrants), or (ii)&nbsp;a number of shares of Common Stock determined by the Registrant&#146;s board of directors.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This estimate is made pursuant to Rule 457(h)(1) and Rule 457(c) of the Securities Act solely for purposes of
calculating the registration fee. The price per share and aggregate offering price of the 2016 ESPP Evergreen Shares are based upon the average of the high and low prices of the Common Stock on February 27, 2025, as reported on the Nasdaq Stock
Market, which date is within five (5)&nbsp;business days prior to the filing of this Registration Statement, multiplied by 85%, which is the percentage of the price per share applicable to purchasers under the 2016 ESPP. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Registrant does not have any fee offsets. </P></TD></TR></TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g892172dsp6c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g892172dsp6c.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$  @&!@<&!0@'!P<*"0@*#18.#0P,#1L3%! 6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$ :(   $% 0$! 0$!           ! @,$!08'" D*"P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M&,Q%SR.O/M63JM55'H=BHWPKK>?^1)_PFEU_SQ'YC_"NA^1Y_M'>Q!-XUO\
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M36?BV[G7YE .?4?X5A1Q<ZDU&QT5\-&E%NY(WBJZ25E* @>X_P *FMC9PJN
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=Z79_A_F9TMRDFW ;CUJ%A)KJB_[4H]G^'^9__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g892172g15i76.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g892172g15i76.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M6'<$9!K)JVAJG?5#Z!A0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MD\L5S"JP-<(9("IEC7&2OKU'!P>1Q1RL.9&AIVI0ZBLPC22*2!_+EBE7:R'
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M:5>RSQPE<_\  E;]#6U[I^1E:S1[)7.;!0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!S_BW5;K3
MM.ABT^4QWUS)LB81&3: "Q.T Y&%QT_B%5%7>I,G;8QWU>_G6\U"TU:X%N-)
M^WQ0F.,A7._Y3\N<#:.,YXJK+:PKO<T/$^M7NGZ39+8N1?W/SC$)D^5%W-\H
M!ZG:N>V^E%)O4<G9:&5J'BZ]@&I7L,JG3GM8S:OL&896BWH3ZANG/0@#O5**
MV)<B[?ZA?:5?:S*VIW,T5I;1200&.,AI)"ZJO";B,A<<Y^M))-(;;1K>%]2E
MU'1_])E,MW;R-!,YC,98J>&VD#&5*MC'>IDK,<7=&U4E!0 4 % !0 4 8/B"
M[O;":VN1++#I<8)N9(%1G4Y&"P8'Y,;L[>>E5%)DO0QG\577]JZRBS$6X@G%
MGF$@+)"/F(8C#9.[C)^Y5<NB%S:EW0-<OKS5X--O747,-FSW"A0!(VY-D@]F
M5CQV.1VI222N@3=[&=)K6K6N@VVI_P!HF:6[\]3"\:83:DC!EP >-@SG/!IV
M5["NTKCSKNK0C6+YC<2PV2KL&(A "8(V^;_EIP6)..,466B'=EF[U:ZT^X73
M1J4\MU<20K]HFAC$<:.2-R;1SDC: V>2.O<2OJ%[:&OI-S=#5=2TZXN3=+:^
M6R3,H#?.#E6V@#(QGH.&%2]KE+>QPO@N2-O%?BVTW!9Y9F*GO@.P/ZD5TUO@
MBSDH_')'E-S;RV=S+;S*4EB8HZGJ"*[4[JZ.%JSLSLO$NF1^"+_2;W19I4N)
M8F<M*0^#@#@8]":YZ<O:IJ1T5(^Q:<3D+V\GU"]FO+I]\\S;G; &3]!6Z2BK
M(YVW)W9Z%K.[2_A#IUC>#;<W#J41NH&XO^@Q^=<L/>K-HZY^[029ZGH7_(O:
M9_UZQ_\ H(KDG\3.V'PHPO$'B*SCUIM$F\.7.KM%;B[<1Q1R!4+%<A6(R<CH
M*<8NU[B;UM8WM%O[#5-'MKS2RILI4S'M7: .F,=B#D8J6FG9E)IK0R/%&N6M
MG?:?H\VA2:O-?"1XX56,@;,9)WD#O515];V$W;0U]'E:;3(F.F/IN,J+9]H*
M '_9)%2]&-'.ZGXP:UU^#2Y/"M_<73-(UJP\KYPG#.N6XX/?!YJU'2]R7*SM
M8ZK"I&]TMM^^,>2H WM@9"YJ"SEK+Q@VL:Q/HDOA>_5XC&+H3>4R1*_*EAN.
M1@9XS5N-E>Y"E=VL;NH7-EX:T*\OTM%2WM8FF:.! N0!G@<#-0KR=BGHCF[_
M .).B0>#++7IK:::VOW,*V^U2^>0P8$XP-IS]15JF^:Q+FK7.KMM,T^UD$UM
M86T$F/O1Q*IQ]0*B[*LD8-UXN=M9U+1[3P[>ZBUEL6=HC$$^==P&&89XJE'2
M]Q<VMK'11VUN\5N3:1IY0!C4H/W7'0>GIQ4E')M\1;2,7$USH^H1Z9!=-:2W
MNU&B5@VTD@-N SWQWJ_9^9'.=5::;86+.]G96]N7^\88E3=]<#FH;;W*LD6J
M0RO!86=M<2W$%I!%-+_K)$C"L_U(ZT[L+$SHDD;1R*'1AAE89!'H:0#3;PE8
MU,*%8B#&-H^0@8&/2@"2@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H C:WA>XCG:-3+&I5'(Y4
M'&0/K@?E0!1GMM'L$"316T"77^C , !)N).SWR2QQ[FGJQ:(CM+70]+\R6UC
MMH#"_D.RX&QFV_+[9^3CZ4W=AHBG->>$[6TN[:62P2VR([A" 4XSPW;C!^F*
M=I"]U%G[?X?N76X:>T9W>(!V(R6W-Y77ONW8]\TK-#NC1MQ:&XNFMQ'YOF 3
ME.NX*,;O?;M_#%("Q2&% !0!!>7MKI]N9[N=((@0-SG R>@^M-*^P7L-_M&S
M\RUC^TQ[[M2T"[N9 !DD>O'-%F*XB:G8R*2EW$P$QMSA@<2 X*?7VHLPNC/O
MKCP]<ZEY5ZUI+=V8+D2 $Q #=D^G&#37,EH)V!;CPY/I#S"2S;3[3<6)QMBR
MISGTR&/U!]Z/>3#2Q;5]*CU%2IMUO5ML@C&\09_/;G\*6MAZ&?%'X6M9TBB2
MQ26]3Y54#,B/_1OR-/WA:(=$OADZG#+%]C-[<KE"N-SKC;^6!C\*/>L&A% G
MA*%;V&%-.5 F+D +M"@]#VP">G8T_>#W32T<Z5]C/]D>1]G#G=Y./O=\^_3K
M4N_4:MT/ [[5+O1O'&H7UE)LFCNY<9Y!&XY!'<&O345*FDSRG)PJ-HV;OQCX
M<UAQ<ZOX8\R\P SQ3;0WUZ?KFLU2G'2,M#5U:<M91U,WQ)XN3Q#J-A,^G+';
MV? A,F=ZY!P3CCIBJITN1-7W(J5>=IVV+T?BGPM;RBZ@\(J+I3E0T^4!^G_U
MJGV=1Z.12JTUJHG/Z]X@O_$5_P#:KUQ\HQ'&G"H/0?XUK""@K(RJ5'-W9]#Z
M%_R+VF?]>L?_ *"*\R?Q,]6'PHYLW,%K\6;Z6XF2*--%C+.[!0!YS=2:K['S
M%M(D^&Z-_P (U<7 !%M=7UQ/; C'[IG.T@>AZ_C14W"&Q1\8PW$_Q"\+1VFH
MG3YC!=XG$:OM^5.,-QS3AI%BE\2.WL\_8XE:Y%RZJ%:8 #>PZG X'/:LF:'*
MZP0/BEX8R/\ EUN\?DE:+X&0_B1V-9EG': 1_P +,\8#'/EV?_HMJT?PHA?$
MR]X^8)X UXGC_0Y!^8I0^)#E\+/*_$/A^\L;'Q2)HV72[$)-9$K@%KB2(O@]
M\;2/;<:VC).QDU:Y[LOW%^E<QN>>Z=#=2?$OQ1+;ZU]A@BEM#-$8D83#RNA+
M<CC(X]:U?PK0S7Q,]#!! (.161H>)+!>2V;6U[J!7PU?>()[>[BCB 93YA*9
M?^Z6 !Z8KHTZ;V,?RN>V@   < 5SFP4 % !0 4 % !0 4 % !0 4 % !0 4
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M <T^9[BLC1 P,"D,* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M,F]T&QU"]-Y-)+AD1)$63$<@1BR[AWP2?ZU2;6@K7(H?#=G;P+#]INF@6598
MXWERJ,'W#''K1S,7*-'AC2W1T9Y97D619':7+OO*%B3Z_NU'L!1S,.5$D_AK
M2KFZNKLQLLUT8V=XY"I#IG:RXZ-SU'7O1S-:#LBYINFPZ:DPCDEE>:3S)))7
MW,S;0O\ )0/PI-W!*Q=I#"@ H * "@ H S;W1[>^NTFN+BXPF&6(2D(&'1L>
MH//U IIV$U<KMX5T8P0PBV")%!]G&QMI*Y4C)'.044@]0:?,Q<J+-II%K:FX
M/F2SSW"!))9I-SE1G ]@,GIZFDV.UA!HNGJE@'C#QV$1BA60Y4# &3GJ<#&?
M<^M%V%D4QX3TJ-$C7SDAVJC1"4A)%5B55AW R0/;CD4^9BY4.;PS8O).&N+D
MI+*9_*\[ 20MNWKCD$'WHYF'*B]IVG6UAYS0N\LTS!I99'WNY P,GT [#BDW
M<:5B]2&% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % &9XDCDE\+ZM%"C/*]I*J*HR22AP *<=T)['&V5
MG)',K7%G)-HPNP\JQV;QHW[D!3Y/)*JPY/()(/:M&_O(2)+FS\NT-S%9RO''
M<S/I]A/:/)'(A5/E*X_=DL&*DXP&/&*$P)KW0UCO-8GMM)" RVI<0P@.\7'G
M*A'7(SD#KT[T)[:@T1WVE+J%VR:7;7%GILEQ;;6CA:+;*OF$R*I QC]WDXP2
M/:A.VX6OL;_A4WSIJDFHVS07+7F&&"%8B*-2R^JD@D5$K:6*C?J=!4E!0 4
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=PQ;$2988A*JV+6[!MO1B?OG.>?\ &IGN..Q__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g892172g94i30.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g892172g94i30.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MV>XM-B>/3[*&&2&*S@2*3[Z+& K?48YHNQV([>STQ//AMK:U7D+,D:*.V0&
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M=2.33=(MXI9I;*SBCVDR.T2 8ZG)QT^M.[%9#=-;19=QTLV+[#DFVV':2/\
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+@ H * "@ H __]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
